Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053900998> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2053900998 endingPage "82" @default.
- W2053900998 startingPage "79" @default.
- W2053900998 abstract "Seven patients, 3 men and 4 women 48-72 years of age and suffering from idiopathic myelofibrosis were given a combination of recombinant human erythropoietin (r-hu-Epo), interferon-alpha-2b (IFN) and GM-CSF, in an attempt to treat their pancytopenia and marrow fibrosis. The dose of r-hu-Epo was 200 U/kg 3 times weekly, that of IFN was 3 x 10(6)/U 3 times weekly, and that of GM-CSF was 250 micrograms/m2/daily. The duration of therapy ranged from 3 to 6 months for r-hu-Epo and IFN and was 3 weeks for GM-CSF. The treatment regimen had a beneficial effect on all patients. The levels of hemoglobin increased in all patients but particularly in 5 (2 of whom had been dependent on red blood cell transfusions). Splenomegaly decreased significantly in 4 patients. Fibrosis in the bone marrow decreased in 2 patients. Three patients also had an increase in the number of white blood cells during the therapy with GM-CSF. We observed mild side effects in 6 of our patients. One patient had severe side effects from IFN and treatment was discontinued. In conclusion, the combination of r-hu-Epo, IFN and GM-CSF may improve the anemia (due to r-hu-Epo), increase the white blood cell count (due to GM-CSF) and reduce the marrow fibrosis (probably due to IFN) in patients with idiopathic myelofibrosis." @default.
- W2053900998 created "2016-06-24" @default.
- W2053900998 creator A5011142806 @default.
- W2053900998 creator A5011573399 @default.
- W2053900998 creator A5037169434 @default.
- W2053900998 creator A5042462369 @default.
- W2053900998 creator A5045356782 @default.
- W2053900998 creator A5056251565 @default.
- W2053900998 creator A5074116917 @default.
- W2053900998 date "1996-01-01" @default.
- W2053900998 modified "2023-10-15" @default.
- W2053900998 title "Combination Therapy with Recombinant Human Erythropoietin, Interferon-α-2b and Granulocyte- Macrophage Colony-Stimulating Factor in Idiopathic Myelofibrosis" @default.
- W2053900998 doi "https://doi.org/10.1159/000203720" @default.
- W2053900998 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8701705" @default.
- W2053900998 hasPublicationYear "1996" @default.
- W2053900998 type Work @default.
- W2053900998 sameAs 2053900998 @default.
- W2053900998 citedByCount "21" @default.
- W2053900998 countsByYear W20539009982012 @default.
- W2053900998 countsByYear W20539009982014 @default.
- W2053900998 countsByYear W20539009982019 @default.
- W2053900998 crossrefType "journal-article" @default.
- W2053900998 hasAuthorship W2053900998A5011142806 @default.
- W2053900998 hasAuthorship W2053900998A5011573399 @default.
- W2053900998 hasAuthorship W2053900998A5037169434 @default.
- W2053900998 hasAuthorship W2053900998A5042462369 @default.
- W2053900998 hasAuthorship W2053900998A5045356782 @default.
- W2053900998 hasAuthorship W2053900998A5056251565 @default.
- W2053900998 hasAuthorship W2053900998A5074116917 @default.
- W2053900998 hasConcept C126322002 @default.
- W2053900998 hasConcept C203014093 @default.
- W2053900998 hasConcept C2776178377 @default.
- W2053900998 hasConcept C2776581026 @default.
- W2053900998 hasConcept C2776694085 @default.
- W2053900998 hasConcept C2778248108 @default.
- W2053900998 hasConcept C2778488018 @default.
- W2053900998 hasConcept C2778534260 @default.
- W2053900998 hasConcept C2779382419 @default.
- W2053900998 hasConcept C2780007613 @default.
- W2053900998 hasConcept C2780076729 @default.
- W2053900998 hasConcept C2780559512 @default.
- W2053900998 hasConcept C71924100 @default.
- W2053900998 hasConcept C90924648 @default.
- W2053900998 hasConceptScore W2053900998C126322002 @default.
- W2053900998 hasConceptScore W2053900998C203014093 @default.
- W2053900998 hasConceptScore W2053900998C2776178377 @default.
- W2053900998 hasConceptScore W2053900998C2776581026 @default.
- W2053900998 hasConceptScore W2053900998C2776694085 @default.
- W2053900998 hasConceptScore W2053900998C2778248108 @default.
- W2053900998 hasConceptScore W2053900998C2778488018 @default.
- W2053900998 hasConceptScore W2053900998C2778534260 @default.
- W2053900998 hasConceptScore W2053900998C2779382419 @default.
- W2053900998 hasConceptScore W2053900998C2780007613 @default.
- W2053900998 hasConceptScore W2053900998C2780076729 @default.
- W2053900998 hasConceptScore W2053900998C2780559512 @default.
- W2053900998 hasConceptScore W2053900998C71924100 @default.
- W2053900998 hasConceptScore W2053900998C90924648 @default.
- W2053900998 hasIssue "2" @default.
- W2053900998 hasLocation W20539009981 @default.
- W2053900998 hasLocation W20539009982 @default.
- W2053900998 hasOpenAccess W2053900998 @default.
- W2053900998 hasPrimaryLocation W20539009981 @default.
- W2053900998 hasRelatedWork W1992627099 @default.
- W2053900998 hasRelatedWork W2028590432 @default.
- W2053900998 hasRelatedWork W2350976758 @default.
- W2053900998 hasRelatedWork W2375099164 @default.
- W2053900998 hasRelatedWork W2400777348 @default.
- W2053900998 hasRelatedWork W2672564533 @default.
- W2053900998 hasRelatedWork W2966858136 @default.
- W2053900998 hasRelatedWork W3206754521 @default.
- W2053900998 hasRelatedWork W4232489820 @default.
- W2053900998 hasRelatedWork W4385252351 @default.
- W2053900998 hasVolume "96" @default.
- W2053900998 isParatext "false" @default.
- W2053900998 isRetracted "false" @default.
- W2053900998 magId "2053900998" @default.
- W2053900998 workType "article" @default.